Kezar Life Sciences, Inc.
Biotechnology · Healthcare
CFO
2026-05-11–present
CFO
Kezar Life Sciences, Inc.
Equibles does not estimate personal net worth.
Michael Hearne is recorded as CFO at Kezar Life Sciences, Inc. since May 11, 2026. Kezar Life Sciences, Inc. reported in an 8-K filed May 11, 2026 that Michael Hearne was appointed Chief Financial Officer, effective May 11, 2026. Kezar Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“The executive officers of Merger Sub immediately prior to the Effective Time were Kevin Tang, Chief Executive Officer, Ryan Cole, Chief Operating Officer, Michael Hearne, Chief Financial Officer, and Stephen Robertson, Chief Legal Officer, Corporate Secretary and Chief Compliance Officer.”
Kezar Life Sciences, Inc.
CFO
SEC 8-K
2026-05-11–present
Kezar Life Sciences, Inc.
Biotechnology · Healthcare
CFO
2026-05-11–present